Literature DB >> 20044219

Differential activation of the Toll-like receptor 2/6 complex by lipoproteins of Streptococcus suis serotypes 2 and 9.

Paul J Wichgers Schreur1, Johanna M J Rebel, Mari A Smits, Jos P M van Putten, Hilde E Smith.   

Abstract

Streptococcus suis causes invasive infections in pigs and occasionally in humans. Worldwide, S. suis serotype 2 is most frequently isolated from diseased piglets, but the less virulent serotype 9 is emerging, at least in Europe. We compared the activation of human Toll-like receptors (hTLRs) by S. suis serotype 2 and 9 strains to better understand the role of the innate immune response in fighting S. suis infections. Neither live nor heat-killed log phase grown S. suis activated the hTLR1/2, hTLR2/6 and hTLR4/MD-2 complexes. However, the hTLR2/6 complex was specifically activated by both serotypes after disruption of the cell wall synthesis using penicillin. Activation levels of the hTLR2/6 complex were higher for serotype 9 strains compared to serotype 2 strains suggesting intrinsic differences in cell wall composition between both serotypes. The hTLR2/6 activating fractions decreased in molecular size after digestion with proteinase K and were sensitive for lipoprotein lipase digestion and NaOH hydrolysis, indicating lipoprotein(s) as active component(s). Overall, our results indicate that S. suis lipoproteins activate TLR2/6 but not TLR1/2 and that the clinically different serotypes 2 and 9 display differential release of TLR ligand when cell wall integrity is compromised. (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20044219     DOI: 10.1016/j.vetmic.2009.12.010

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  15 in total

1.  In vitro characterization of the microglial inflammatory response to Streptococcus suis, an important emerging zoonotic agent of meningitis.

Authors:  María de la Cruz Domínguez-Punaro; Mariela Segura; Irazú Contreras; Claude Lachance; Mathieu Houde; Marie-Pier Lecours; Martin Olivier; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

2.  The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles.

Authors:  Massimiliano Biagini; Manuela Garibaldi; Susanna Aprea; Alfredo Pezzicoli; Francesco Doro; Marco Becherelli; Anna Rita Taddei; Chiara Tani; Simona Tavarini; Marirosa Mora; Giuseppe Teti; Ugo D'Oro; Sandra Nuti; Marco Soriani; Immaculada Margarit; Rino Rappuoli; Guido Grandi; Nathalie Norais
Journal:  Mol Cell Proteomics       Date:  2015-05-27       Impact factor: 5.911

3.  Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals.

Authors:  Cynthia Calzas; Paul Lemire; Gael Auray; Volker Gerdts; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

4.  Response of swine spleen to Streptococcus suis infection revealed by transcription analysis.

Authors:  Ran Li; Anding Zhang; Bo Chen; Liu Teng; Ya Wang; Huanchun Chen; Meilin Jin
Journal:  BMC Genomics       Date:  2010-10-11       Impact factor: 3.969

5.  Characterization of porcine dendritic cell response to Streptococcus suis.

Authors:  Marie-Pier Lecours; Mariela Segura; Claude Lachance; Tufaria Mussa; Charles Surprenant; Maria Montoya; Marcelo Gottschalk
Journal:  Vet Res       Date:  2011-06-02       Impact factor: 3.683

6.  Lgt processing is an essential step in Streptococcus suis lipoprotein mediated innate immune activation.

Authors:  Paul J Wichgers Schreur; Johanna M J Rebel; Mari A Smits; Jos P M van Putten; Hilde E Smith
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

7.  Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival.

Authors:  Marjolein Meijerink; Maria Laura Ferrando; Geraldine Lammers; Nico Taverne; Hilde E Smith; Jerry M Wells
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

8.  Lysozyme resistance in Streptococcus suis is highly variable and multifactorial.

Authors:  Paul J Wichgers Schreur; Christian van Weeghel; Johanna M J Rebel; Mari A Smits; Jos P M van Putten; Hilde E Smith
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

9.  Immune receptors involved in Streptococcus suis recognition by dendritic cells.

Authors:  Marie-Pier Lecours; Mariela Segura; Nahuel Fittipaldi; Serge Rivest; Marcelo Gottschalk
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Toll-like receptor 2-independent host innate immune response against an epidemic strain of Streptococcus suis that causes a toxic shock-like syndrome in humans.

Authors:  Claude Lachance; Mariela Segura; Pehuén Pereyra Gerber; Jianguo Xu; Marcelo Gottschalk
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.